MSD Dunboyne is MSD’s first Biologics Drug Substance Single Use Commercialisation Facility, playing an important role in helping to commercialise key medicines.
The innovation and collaboration between MSD Dunboyne’s research and manufacturing teams will significantly accelerate the time it takes to bring a medicine to market, benefiting patients world-wide.
MSD Dunboyne is also part of the broader MSD network. For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.